{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T12:17:08Z","timestamp":1784204228867,"version":"3.55.0"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,21]],"date-time":"2025-05-21T00:00:00Z","timestamp":1747785600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272753"],"award-info":[{"award-number":["82272753"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2021LZL002"],"award-info":[{"award-number":["ZR2021LZL002"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["flzh202103"],"award-info":[{"award-number":["flzh202103"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014103","name":"Key Technology Research and Development Program of Shandong Province","doi-asserted-by":"publisher","award":["2021SFGC05012021"],"award-info":[{"award-number":["2021SFGC05012021"]}],"id":[{"id":"10.13039\/100014103","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.crad.2025.106954","type":"journal-article","created":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T02:29:36Z","timestamp":1747189776000},"page":"106954","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Imaging pancreatic cancer with [18F]F-AlF-NOTA-FAPI-04 positron emission tomography\/computed tomography (PET\/CT): distribution patterns and therapeutic implications"],"prefix":"10.1016","volume":"87","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4451-0822","authenticated-orcid":false,"given":"C.","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5242-6554","authenticated-orcid":false,"given":"J.","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.crad.2025.106954_bib1","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(10)62307-0","article-title":"Pancreatic cancer","volume":"378","author":"Vincent","year":"2011","journal-title":"The Lancet"},{"key":"10.1016\/j.crad.2025.106954_bib2","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1038\/s41388-018-0275-3","article-title":"Pro-tumorigenic roles of fibroblast activation protein in cancer: back to the basics","volume":"37","author":"Pur\u00e9","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.crad.2025.106954_bib3","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.92232","article-title":"Fibroblast activation protein augments progression and metastasis of pancreatic ductal adenocarcinoma","volume":"2","author":"Lo","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/j.crad.2025.106954_bib4","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1007\/s00259-023-06271-8","article-title":"[18F] AlF-NOTA-FAPI-04 PET\/CT can predict treatment response and survival in patients receiving chemotherapy for inoperable pancreatic ductal adenocarcinoma","volume":"50","author":"Zhu","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2025.106954_bib5","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.crad.2025.106954_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41586-024-07461-6","article-title":"Covalent targeted radioligands potentiate radionuclide therapy","volume":"630","author":"Cui","year":"2024","journal-title":"Nature"},{"key":"10.1016\/j.crad.2025.106954_bib7","unstructured":"Langbein T, Weber WA, Eiber M. Future of theranostics: an outlook on precision Oncology in nuclear medicine [n.d]."},{"key":"10.1016\/j.crad.2025.106954_bib8","doi-asserted-by":"crossref","first-page":"415","DOI":"10.2967\/jnumed.120.259192","article-title":"Feasibility, biodistribution, and preliminary dosimetry in peptide-targeted radionuclide therapy of diverse adenocarcinomas using 177 Lu-FAP-2286: first-in-humans results","volume":"63","author":"Baum","year":"2022","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2025.106954_bib9","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1007\/s00259-021-05638-z","article-title":"[18F]AlF-NOTA-FAPI-04 PET\/CT uptake in metastatic lesions on PET\/CT imaging might distinguish different pathological types of lung cancer","volume":"49","author":"Wei","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2025.106954_bib10","article-title":"18 F-FAPI-04 outperforms 18 F-FDG PET\/CT in clinical assessments of patients with pancreatic adenocarcinoma","volume":"123","author":"Li","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2025.106954_bib11","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1007\/s00259-021-05194-6","article-title":"Non-malignant findings of focal 68Ga-FAPI-04 uptake in pancreas","volume":"48","author":"Zhang","year":"2021","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2025.106954_bib12","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s00259-022-05729-5","article-title":"Comparison of the diagnostic efficacy of 68 Ga-FAPI-04 PET\/MR and 18F-FDG PET\/CT in patients with pancreatic cancer","volume":"49","author":"Zhang","year":"2022","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2025.106954_bib13","doi-asserted-by":"crossref","DOI":"10.1007\/s00259-024-06756-0","article-title":"Diagnostic efficacy of [68Ga]Ga-DOTA-GPFAPI-04 in patients with solid tumors in a head-to-head comparison with [18F]F-FDG: results from a prospective clinical study","author":"Yuan","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2025.106954_bib14","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.220749","article-title":"FAPI PET: fibroblast activation protein inhibitor use in oncologic and nononcologic disease","volume":"306","author":"Mori","year":"2023","journal-title":"Radiology"},{"key":"10.1016\/j.crad.2025.106954_bib15","article-title":"Comparing the clinical value of baseline [68 Ga]Ga-FAPI-04 PET\/CT and [18F]F-FDG PET\/CT in pancreatic ductal adenocarcinoma: additional prognostic value of the distal pancreatitis","volume":"50:4036\u201350.","author":"Ding","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2025.106954_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.molmet.2016.01.002","article-title":"Integration of ATAC-seq and RNA-seq identifies human alpha cell and beta cell signature genes","volume":"5","author":"Ackermann","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/j.crad.2025.106954_bib17","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1007\/s00259-023-06246-9","article-title":"FAP expression in alpha cells of Langherhans insulae\u2014implications for FAPI radiopharmaceuticals\u2019 use","volume":"50","author":"Kirienko","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.crad.2025.106954_bib18","doi-asserted-by":"crossref","first-page":"2798","DOI":"10.3390\/cancers15102798","article-title":"Head-to-Head intra-individual comparison of biodistribution and tumor uptake of [18F]FAPI-74 with [18F]FDG in patients with PDAC: a prospective exploratory study","volume":"15","author":"Novruzov","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.crad.2025.106954_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2967\/jnumed.120.253062","article-title":"Impact of68 Ga-FAPI PET\/CT imaging on the therapeutic management of primary and recurrent pancreatic ductal adenocarcinomas","volume":"62","author":"R\u00f6hrich","year":"2021","journal-title":"J Nucl Med"},{"key":"10.1016\/j.crad.2025.106954_bib20","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.3390\/ph14121212","article-title":"First-in-Human results on the biodistribution, pharmacokinetics, and dosimetry of [177Lu]Lu-DOTA.SA.FAPi and [177Lu]Lu-DOTAGA.(SA.FAPi)2","volume":"14","author":"Ballal","year":"2021","journal-title":"Pharmaceuticals"},{"key":"10.1016\/j.crad.2025.106954_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/bjs\/znae178","article-title":"Neoadjuvant 177Lu-DOTATATE for non-functioning pancreatic neuroendocrine tumours (NEOLUPANET): multicentre phase II study","volume":"111","author":"Partelli","year":"2024","journal-title":"Br J Surg"},{"key":"10.1016\/j.crad.2025.106954_bib22","series-title":"Comparison of 18F-FDG, 68Ga-FAPI, and 68Ga-DOTATATE PET\/CT in a patient with pancreatic neuroendocrine tumor","author":"Cheng","year":"2021"},{"key":"10.1016\/j.crad.2025.106954_bib23","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrgastro.2010.114","article-title":"Etiology and diagnosis of acute biliary pancreatitis","volume":"7","author":"Van Geenen","year":"2010","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.crad.2025.106954_bib24","article-title":"Non-specific uptake of 18F-FAPI-04 in the pancreas and its related factors: a post-hoc analysis of an ongoing prospective clinical trial","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/j.crad.2025.106954_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43049-2","article-title":"Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas","volume":"13","author":"Hoppner","year":"2023","journal-title":"Sci Rep"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000992602500159X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000992602500159X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:13:56Z","timestamp":1762114436000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000992602500159X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":25,"alternative-id":["S000992602500159X"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2025.106954","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imaging pancreatic cancer with [18F]F-AlF-NOTA-FAPI-04 positron emission tomography\/computed tomography (PET\/CT): distribution patterns and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2025.106954","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"106954"}}